Godi, Anna <br/><br/>
Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccine.  [electronic resource] 

 -  Vaccine  04 2019 
 - 2455-2462 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2019.03.052  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antibodies, Neutralizing--blood<br/>Antibodies, Viral--blood<br/>Cross Protection<br/>Female<br/>Genotype<br/>Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18--administration & dosage<br/>Humans<br/>Papillomaviridae--classification<br/>Papillomavirus Infections--immunology<br/>Papillomavirus Vaccines--administration & dosage<br/>Time Factors